Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Neiyifang is a Traditional Chinese Medicine (TCM) herbal formula developed by Shanghai Changhai Hospital for the treatment of endometriosis. It is specifically designed to treat the TCM syndrome of "cold coagulation and blood stasis," which is clinically associated with symptoms such as chronic pelvic pain and dysmenorrhea. The formula is typically administered as a granule and is intended to warm the meridians, promote blood circulation, and resolve stasis to alleviate the growth and symptoms of ectopic endometrial tissue. It is currently being evaluated in multicenter, randomized, double-blind clinical trials to establish its efficacy and safety profile compared to standard treatments or placebo.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Neiyifang (Shanghai Changhai Hospital).